NEI Research News

Researchers at the University of California, Berkeley, find that restoring opsins with gene therapy can make 'blind' cells light-sensitive; potential human treatment within three years.

A new therapy developed by researchers at the University of California, Berkeley, could help prolong useful vision and delay total blindness for people with retinitis pigmentosa.

Cells of the retinal pigment epithelium (RPE) form unique patterns that can be used to track changes in this important layer of tissue in the back of the eye, researchers at the National Eye Institute (NEI) have found.

Researchers at the University of New Hampshire have created a hydrogel that could one day be made into a contact lens to more effectively treat corneal melting.

A team of researchers led by Harvard's Joshua Sanes applied high-throughput genetic sequencing methods to create the first cellular atlas of the primate retina.

A small pilot clinical study at the National Eye Institute (NEI) suggests that the drug nitisinone increases melanin production in some people with oculocutaneous albinism type 1B (OCA-1B), a rare genetic disease that causes pale skin and hair and poor vi

Neurons somehow know which of their neighbors to connect with and which to avoid in the crowded environment of the central nervous system. But how?

Robert Nussenblatt, M.D., chief of the Laboratory of Immunology at the National Eye Institute (NEI), died on April 17 at age 67.

Scientists from the Medical College of Georgia at Augusta University have discovered that removing a pro-inflammatory enzyme promotes regeneration after an injury to the optic nerve.

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration (AMD), a leading cause of vision loss and blindness among people age 65 and older.